Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sanna Bastiano
Relationship:   Director
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   37,938    

Indirect Shares

   0      
Direct Value   $13,553,699    

Indirect Value

   $0      
Total Shares   37,938      
Total Value   $13,553,699      


Vertex Pharmaceuticals Inc $13,545,026 Adicet Bio, Inc $8,673 Vertex Pharmaceuticals Inc $13,545,026 Adicet Bio, Inc $8,673
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Cell & Genetic Th... 2023-05-08 32,038 2021-02-03 0    Premium*  
            Adicet Bio, Inc ACET Director 2023-06-01 5,900 2023-06-01 0    Premium*  
* Premium Members only  

Records found :    43         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACET Adicet Bio, Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 5,900 5,900 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic TherapiesO   •       –      –    2021-02-03 3 IO $0.00 $0 D/D 0 21,175 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-02-03 4 A $0.00 $0 D/D 20,719 41,894 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-02-10 4 D $214.16 $287,831 D/D (1,344) 40,550 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-02-11 4 AS $210.44 $355,012 D/D (1,686) 38,864 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-04-05 4 AS $213.89 $361,046 D/D (1,686) 35,834 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-04-30 4 D $217.21 $166,383 D/D (766) 35,068 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-05-03 4 AS $218.06 $209,691 D/D (960) 34,108 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-05-17 4 AS $215.95 $24,230 D/D (112) 34,108 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-07-30 4 D $200.39 $153,499 D/D (766) 33,342 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2021-11-01 4 D $185.07 $141,764 D/D (766) 32,576 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-02-01 4 D $243.64 $128,155 D/D (526) 55,992 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-02-01 4 A $0.00 $0 D/D 23,942 56,518 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-02-02 4 AS $250.04 $261,017 D/D (1,040) 54,952 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-02-10 4 D $237.74 $232,747 D/D (979) 53,973 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-02-17 4 D $232.51 $799,602 D/D (3,439) 50,534 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-03-17 4 AS $250.06 $530,627 D/D (2,122) 48,412 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-04-01 4 D $263.09 $353,593 D/D (1,344) 47,068 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-04-04 4 AS $267.10 $150,452 D/D (562) 46,506 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-04-05 4 AS $275.23 $870,552 D/D (3,163) 43,343 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-04-07 4 AS $275.71 $154,935 D/D (561) 42,782 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-04-29 4 D $276.17 $211,546 D/D (766) 42,016 0 -
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-05-02 4 AS $255.47 $82,930 D/D (320) 41,696 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-05-16 4 AS $250.56 $11,377 D/D (45) 41,749 0 %
VRTX Vertex Pharmaceuticals In... EVP, Cell & Genetic Therapies   •       –      –    2022-08-01 4 D $276.62 $211,891 D/D (766) 40,983 0 -
  43  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us